Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Therapeutic Drug Monitoring|April 10, 2007
13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants: a pilot studySaskia N de Wildt, Michiel J P Berns, John N van den Anker
Clinical Chemistry|June 23, 2017
Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical PracticeMaja Matic, Saskia N de Wildt, Dick Tibboel, et al.
The Annals of Pharmacotherapy|April 2, 2014
Propylene Glycol-Related Delirium After Esmolol InfusionBerber Kapitein, Renee C G Biesmans, Heleen van der Sijs, et al.
Drug Discovery Today|December 9, 2008
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modelingIbrahim Ince, Saskia N de Wildt, Dick Tibboel, et al.
Frontiers in Pediatrics|September 9, 2016
Sedation in Critically Ill Children with Respiratory FailureNienke J Vet, Niina Kleiber, Erwin Ista, et al.
Journal of Medical Internet Research|December 13, 2021
CE Accreditation and Barriers to CE Marking of Pediatric Drug Calculators for Mobile Devices: Scoping Review and Qualitative AnalysisCharlotte Koldeweij, Jonathan Clarke, Joppe Nijman, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 13, 2012
Ontogeny of oral drug absorption processes in childrenMiriam G Mooij, Barbara A E de Koning, Mark L Huijsman, et al.
British Journal of Clinical Pharmacology|February 16, 2026
Beyond the label: Rethinking off-label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapyTjitske M van der Zanden, Miriam G Mooij, Matthijs de Hoog, et al.
Archives of Toxicology|July 16, 2021
Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modellingLaurens F M Verscheijden, Jan B Koenderink, Saskia N de Wildt, et al.
Pageof 21